53. Sjogren syndrome Clinical trials / Disease details

Clinical trials : 283 / Drugs : 320 - (DrugBank : 101) / Drug target genes : 56 - Drug target pathways : 181

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01584947 (ClinicalTrials.gov)	April 2012	23/4/2012	Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Chronic Oral Pain	Clinical Trials With a Local Anesthetic Lozenge for the Treatment of Oral Mucosal Pain in Burning Mouth Syndrome, Sjögrens Syndrome and Lichen Planus.	Chronic Pain	Drug: Bupivacaine;Drug: Placebo	Hvidovre University Hospital	Oracain II Aps	Terminated	18 Years	75 Years	Both	31	Phase 2	Denmark
2	EUCTR2011-006196-19-DK (EUCTR)	28/02/2012	30/01/2012	Clinical Trials with lozenge as local anaesthesia as treatment for oral pain of patients with burning mouth syndrome and Sjögrens syndrom	Clinical Trials with lozenge as local anaesthesia as treatment of oral pain in burning mouth syndrome and Sjögrens syndrome - SB Lozenge	Oral pain caused by the illnesses burning mouth syndrome, Sjögren's syndrome and lichen planus;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]	Product Name: Bupizenge Product Code: BUPI5 INN or Proposed INN: BUPIVACAINE HYDROCHLORIDE	Clinical Research Centre, Hvidovre University Hospital	NULL	Not Recruiting			Female: yes Male: yes	60	Phase 2	Denmark